Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

NCT02748564 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Study Complete

Conditions

Metastatic Melanoma
Stage III Mucosal Melanoma of the Head and Neck
Stage IIIA Skin Melanoma
Stage IIIB Skin Melanoma
Stage IIIC Skin Melanoma
Stage IV Skin Melanoma
Stage IVA Mucosal Melanoma of the Head and Neck
Stage IVB Mucosal Melanoma of the Head and Neck
Stage IVC Mucosal Melanoma of the Head and Neck

Interventions

BIOLOGICAL: Aldesleukin
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pembrolizumab

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]